Acton

Product Insight, Inc., an Acton-based product development firm, has leased 21,512 square feet of space at 80 Central St. in Boxborough, part of a 375,000-square-foot campus called Tech Central.

Employees are on the move at Akoya Biosciences, Milford Regional Medical Center, and MutualOne Bank, with new hires joining operations and promotions happening within organizations.

Acton-based Insulet, a medical device firm specializing in diabetes treatment, has acquired $25 million in assets from Automated Glucose Control LLC in California.

Acton medical device firm Insulet has acquired $25 million of diabetes pump technology from California-based Bigfoot Biomedical, nearly doubling Insulet’s intellectual property.

The landscape for women’s business leadership at the highest level in Central Mass. has taken a hit, but for women professionals in the region, it is yet another motivator to empower one another in traditional and non-traditional ways.

Neil Gordon, the CEO of the Discovery Museum in Acton, will retire on Dec. 31 after 14 years of leading the organization.

Acton medical device manufacturer Insulet Corp. issued a voluntary medical device correction on its Omnipod DASH Personal Diabetes Manager on Oct. 17.

Will a big bank like Chase put Central Massachusetts-headquartered banks at a disadvantage? Industry leaders here don’t think so.

When Shacey Petrovic stepped down as CEO of Acton medical-device company Insulet in May for personal reasons, she left Central Massachusetts without a single public company headquartered here, traded on NASDAQ or New York Stock Exchange, with a woman as CEO.

The U.S. Food and Drug Administration has cleared an insulin delivery system from Acton medical device firm Insulet Corp. for children two years and older with type 1 diabetes.